has server used (Russian Federation) ping response time Hosted in Register Domain Names at . This domain has been created Unknown ago, remaining Unknown. You can check the 11 Websites and blacklist ip address on this server

Domain information

  Sign up for notifications near expiration

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email,280,, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a[email protected],, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions


Neovasculgen price

Neovasculgen fda drug approval

( Please select at least 2 keywords )

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

Hosting Provider


IP Server: Reg: , Updated:

Blacklist: Check Backlist Status

Country: Russian Federation

Latitude: 55.738602

Longitude: 37.606800

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

No Emails Found

Find Websites hosted





5: Changed to:

6: Changed to:

7: Changed to:





At least 11 Sites on this server

Port Scanner (IP:

API Neovasculgen

  • Cambiogenplasmid, marketed as Neovasculgen, is a gene therapy drug for treatment of peripheral artery disease, including critical limb ischemia; it delivers the gene encoding for vascular endothelial growth factor (VEGF)
  • Neovasculogen is a plasmid encoding the CMV promoter and the 165 amino acid form of VEGF.   DA: 14 PA: 11 MOZ Rank: 25

NEOGOV HR Software For The Public Sector

  • NEOGOV’s HR suite empowers public sector HR to streamline processes in a centralized platform
  • Cumbersome manual processes are no longer the accepted norm for HR teams in the public sector
  • NEOGOV's three integrated, cloud-based modules   DA: 14 PA: 14 MOZ Rank: 29

Vascular Endothelial Growth Factor Gene Therapy

  • Login with a username/password associated to your organization’s account
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
  • Federated access using single sign-on credentials
  • Contact us at [email protected] for assistance.   DA: 24 PA: 16 MOZ Rank: 42

HSCI Receives Approval To Market Neovasculgen – The First

  • Neovasculgen® is designed to treat Peripheral Arterial Disease (PAD), including Critical Limb Ischemia (CLI), caused by atherosclerosis (a thickening of artery walls and subsequent reduction of blood flow)
  • According to HSCI’s data, in Russia each year approximately 144,000 patients are diagnosed with CLI and 30,000-40,000 patients undergo   DA: 11 PA: 50 MOZ Rank: 64

NeoLife Vitamin Shop

  • Your online store for NeoLife products
  • Find vitamin supplements from GNLD NeoLife, home care products from Golden, and skin care from Nutriance
  • Buy Pro Vitality, NeoLife Shake Protein, Salmon Oil Plus, Carotenoid Complex, Calcium, CoQ10, Iron, Vitamin C, Zinc and many other organic vitamins.   DA: 22 PA: 22 MOZ Rank: 48

Contact Us NEOGEN

  • Neogen Bio-Scientific Technology (Shanghai) Co., Ltd
  • Room 101-104, Building 13 & Room 402, Building 8, Health Work Park, 697 Lingshi Road, Jingan District,   DA: 14 PA: 9 MOZ Rank: 28

HSCI Receives Approval To Market Neovasculgen – The First

  • Sale of Neovasculgen® is scheduled to begin in Q2 2012 upon certification of the drug’s first batches
  • In 2012 HSCI will seek to include this new drug in federal and regional public medicine subsidy programs
  • Following successful promotional activities, Neovasculgen® sales should account for a substantial portion of the Company’s revenues.   DA: 22 PA: 50 MOZ Rank: 78

Efficiency, Safety And Portability Of Neovasculgen

  • This study demonstrated the safety, feasibility, and short-term (3 months) efficacy of pCMV-vegf165 gene transfer,12,13which lead to conducting a phase 2b to 3 multicenter clinical trial
  • The study was conducted under the control of the Russian Ministry of Health and was completed in 2011
  • Patients enrolled in the study were subjected to a 6-month.   DA: 18 PA: 21 MOZ Rank: 46

Gene Therapy Market, 2015

  • Gendicine became the first approved gene therapy in China in 2004
  • So far, there have been three more marketed gene therapies: Rexin-G, Oncorine and Neovasculgen
  • All of these have been made commercially available in Asian countries
  • Glybera was the first gene therapy to …   DA: 21 PA: 50 MOZ Rank: 79

Safety And Efficacy Study Of Neovasculgen (Pl-VEGF165

  • This is a open clinical trial assessing the therapeutic efficacy of pl-vegf165 (Neovasculgen) in treating ulcers related to diabetic foot syndrome
  • Each patient will undergo several intramuscular injections with a treatment dose of pl-vegf165 (Neovasculgen) in calf of affected extrimity.   DA: 18 PA: 21 MOZ Rank: 48

Gene Therapy Net Newsletter

  • Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items
  • Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, …   DA: 22 PA: 18 MOZ Rank: 50

Safety And Efficacy Study Of Neovasculgen (Pl-VEGF165

  • The purpose of this study is to determine safety and efficacy of pl-vegf165 ("Neovasculgen") for regeneration of peripheral nerve
  • Pl-vegf165 ("Neovasculgen") is the permitted in Russian Federation angiogenic medication that induce growth of new vessels and included in a complex therapy for patients with peripheral arterial diseases in Russia.   DA: 18 PA: 21 MOZ Rank: 50

Artgen Final Presentation

Neovasculgen structural map Optimized promoter structure Encoding area of the gene of Vascular growth factor Length of life of gene RNA Biotechnological production of the drug By replacing some nucleotides in the block that controls the length of life of mRNA molecule and the signal for polyadenylation, we were able to find those combinations   DA: 18 PA: 39 MOZ Rank: 69


  • NEOGEN DERMALOGY Probiotics Youth Repair Mist 120ml   DA: 16 PA: 29 MOZ Rank: 58

Safety And Efficacy Study Of Gene Therapy Drug

  • Neovasculgen is an original gene construction that contains supercoiled plasmid DNA (1.2 mg) that encodes pCMV-vegf165 as the active substance
  • The drug will be supplied to the study centre as a sterile lyophilisate that will be then dissolved in …   DA: 18 PA: 21 MOZ Rank: 53

Non-Interventional Post Marketing Surveillance Study Of

  • Information from the National Library of Medicine
  • To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor
  • Please refer to this study by its identifier (NCT number): NCT02369809   DA: 18 PA: 21 MOZ Rank: 54

Neogen Corporation LinkedIn

Neogen Corporation Biotechnology Lansing, MI 17,820 followers The mission of NEOGEN is to be the leading company in the development of solutions for food and animal safety.   DA: 16 PA: 27 MOZ Rank: 59

Oncorine, The World First Oncolytic Virus Medicine And Its

  • This oncolytic virus, enteric cytopathogenic human orphan (ECHO)-7, is a wild-type virus
  • In 2005, the first genetically modified oncolytic virus (Oncorine ® , a recombinant oncolytic adenovirus   DA: 20 PA: 50 MOZ Rank: 87

Canadian Biotech Firm Specializing In Heart Valves

  • Sarah Gallagher joined Neovasc as the Vice President of Clinical Affairs in June of 2021, bringing with her 20 years of medical device clinical research experience
  • Prior to joining Neovasc, Sarah held leaderships roles at Medtronic in Interventional Pain, Neuromodulation, and Cardiac Rhythm Management, and St
  • Jude Medical in Structural Heart.   DA: 15 PA: 12 MOZ Rank: 45

BRIEF-Human Stem Cells Institute To Develop Ischemia Drug

* Neovasculgen is a first-in-class gene therapy drug that was approved in 2011 for human use in Russia for treatment of atherosclerotic Peripheral Arterial Disease, including Critical Limb Ischemia   DA: 15 PA: 22 MOZ Rank: 56

PCMV-vegf165 Intramuscular Gene Transfer Is An Effective

  • "Neovasculgen" is a Russian research product approved for clinical use in Russia and Ukraine [120, 121]
  • The experience of "Neovasculgen" development has been extrapolated to the first clinical   DA: 20 PA: 50 MOZ Rank: 90

Global Cell And Gene Therapy Market: Focus On Product Type

  • Global Cell and Gene Therapy Market: Focus on Product Type, Therapeutic Class, Pipeline, Regional and Country Data (15 Countries) - Analysis and Forecast, 2021-2027
  • Global Cell and Gene Therapy Market to Grow at a CAGR of 33.82% from 2021-2027
  • Market Report Coverage - Cell and Gene Therapy Market Segmentation By Product Type: Yescarta, Prove   DA: 19 PA: 50 MOZ Rank: 90


  • This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia
  • If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks
  • Stub This article has been rated as Stub-Class on the project's quality scale   DA: 16 PA: 23 MOZ Rank: 61

NeoGenomics, Inc. (NEO)

  • specializes in cancer genetic testing and information services
  • The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer
  • The Company’s Pharma Services division serves pharmaceutical clients in clinical trials and drug development.   DA: 18 PA: 18 MOZ Rank: 59

Gene Therapy Market (4th Edition) Industry Analysis

  • Figure 20.1 Global Gene Therapy Market, 2020-2030: Base Case Scenario (USD Billion) Figure 20.2 Gene Therapy Market: Distribution by Therapeutic Approach, 2020, 2025 and 2030
  • Figure 20.3 Gene Therapy Market: Distribution by Type of Gene Therapy, 2020, 2025 and 2030.   DA: 21 PA: 50 MOZ Rank: 95

Ten Years Of Interventional Research In Systemic Sclerosis

  • The ICTRP portal provides a single point of access to information about ongoing and completed clinical trials registered around the world
  • It provides a searchable database containing the trial registration data sets made available by many data providers, including and the European Union Clinical Trials Register.   DA: 23 PA: 22 MOZ Rank: 70

Exclusive Datamonitor Healthcare Report Trends In Gene Therapy

  • Exclusive Datamonitor Healthcare Report Trends in Gene Therapy
  • Gene therapy: it has been heralded as a miracle cure for everything from cancer to rare diseases, but it suffered serious setbacks with high clinical mortalities in the late 1990’s
  • Despite this, gene therapy continues to evolve, and the number of gene therapies in active   DA: 30 PA: 50 MOZ Rank: 24

186. Long-Term Results Of PCMV-vegf165 Intramuscular Gene

  • Restriction of blood flow due to atherosclerosis leads to chronic lower limb ischemia (CLI) affected 3-8% of the general population
  • Current pharmacological therapies have limited effects
  • Therefore, developing new treatments is pivotal
  • Gene therapy is targeted at inducing angiogenesis in ischemic extremities via increased endogenous expression of vascular growth factors.   DA: 12 PA: 50 MOZ Rank: 89

Gene Therapy Market To Be Worth Over USD 10 Billion By

  • Gene Therapy Market to be Worth over USD 10 billion by 2025, predicts Roots Analysis
  • Roots Analysis has announced the addition of “ Gene Therapy Market, 2015-2025 ” report to their offering
  • The market currently has only five approved therapies; of these, four are …   DA: 21 PA: 50 MOZ Rank: 99

Neovasc Receives FDA Approval To Initiate Pivotal Reducer

Login to your account others relating to the Company are discussed in greater detail in the "Risk Factors" section of the Company's Annual Information Form …   DA: 27 PA: 50 MOZ Rank: 21

Recently Analyzed

1: 0 seconds ago

2: 0 seconds ago

3: 1 seconds ago

4: 1 seconds ago

5: 0 seconds ago

6: 1 seconds ago

7: 6 seconds ago

8: 4 seconds ago

9: 2 seconds ago

10: 2 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Thaippe.com4 years, 354 days leftEveryones Internet, Ltd. dba SoftLayerINET IDC HQ Vlan230 102 days, LLCDomain Name Services 214 days leftAlibaba Cloud Computing (Beijing) Co., Ltd.Amazon Technologies Inc. 225 days leftXin Net Technology CorporationNWT iDC Data Service 283 days leftCenter of Ukrainian Internet Names (UKRNAMES)Domain Name Services
Solhop.com7 years, 60 days leftTucows Domains Inc.Cloudflare, Inc.
Thegrovervpark.com1 year, 254 days,, LLC 286 days left1&1 IONOS SELiquid Web, L.L.C
Realpage.com5 years, 350 days, LLCANS Communications, Inc 260 days, LLCConfluence Networks Inc

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 All rights reserved. Email: [email protected]